BCL9 anticorps

N° du produit ABIN7262729

Détail du produit anti-BCL9 anticorps

Antigène: BCL9 (B-Cell CLL/lymphoma 9 (BCL9))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BCL9 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Attributs du produit: Polyclonal Antibody

Purification: Affinity purification

Immunogène: Recombinant protein of mouse Bcl9

Isotype: IgG

Information d'application

Indications d'application: WB 1:500-1:2000 IHC 1:50-1:200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur BCL9

Antigène: BCL9 (B-Cell CLL/lymphoma 9 (BCL9))

Autre désignation: Bcl9 (BCL9 Produits)

Synonymes: anticorps lgs, anticorps xbcl9, anticorps legless, anticorps MGC83888, anticorps BCL9, anticorps 2610202E01Rik, anticorps 8030475K17Rik, anticorps A330041G23Rik, anticorps Gm130, anticorps LGS, anticorps B-cell CLL/lymphoma 9 L homeolog, anticorps B-cell CLL/lymphoma 9, anticorps B cell CLL/lymphoma 9, anticorps bcl9.L, anticorps BCL9, anticorps Bcl9

Sujet: BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.

Poids moléculaire:

Observed_MW: 160 kDa/170 kDa

Calculated_MW: 148 kDa

ID gène: 77578

UniProt: Q9D219

Pathways: Stem Cell Maintenance